Table 1 Patient demographics and... | American Society of Hematology

Table 1

Patient demographics and baseline disease characteristics (N = 25)

Characteristic	No. of patients	% of patients
Age, y
Median	14	—
Range	1-21	—
Sex
Male	16	64
Female	9	36
Race
Black	2	8
American Indian or Alaska Native	1	4
Asian	2	8
White	12	48
Other	8	32
Immunophenotype
B-precursor	21	84
T cell	1	4
Unknown	3	12
Prior regimens
Median	2	—
Range	1-3	—
1 regimen*	4	16
2 regimens	14	56
3 regimens	7	28
Refractory to immediate prior regimen	15	60
Performance status (Karnofsky/Lansky)
50%	2	8
60%	2	8
70%	2	8
80%	3	12
90%	6	24
100%	10	40
Prior HSCT†	4	16

Characteristic	No. of patients	% of patients
Age, y
Median	14	—
Range	1-21	—
Sex
Male	16	64
Female	9	36
Race
Black	2	8
American Indian or Alaska Native	1	4
Asian	2	8
White	12	48
Other	8	32
Immunophenotype
B-precursor	21	84
T cell	1	4
Unknown	3	12
Prior regimens
Median	2	—
Range	1-3	—
1 regimen*	4	16
2 regimens	14	56
3 regimens	7	28
Refractory to immediate prior regimen	15	60
Performance status (Karnofsky/Lansky)
50%	2	8
60%	2	8
70%	2	8
80%	3	12
90%	6	24
100%	10	40
Prior HSCT†	4	16

— indicates not applicable.

Primary refractory (n = 2); 1 patient with first DOR, 31.9 weeks; and 1 patient with first DOR, 206 weeks.

These 4 patients were enrolled before a protocol amendment excluding patients with prior HSCT.